In a co-branded Scientific American-World Economic Forum session at the Annual Meeting of New Champions, or “Summer Davos,” in Tianjin, China, Editor in Chief Mariette DiChristina leads a discussion with Aura Biosciences CEO Elisabeth de los Pinos Pont, Illumina Executive Chairman Jay Flatley and BGI President Wang Jian on how business and government can bridge the gap between availability and access as genomic technologies move from lab to clinic.

Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www.springernature.com/us). Scientific American maintains a strict policy of editorial independence in reporting developments in science to our readers.